+1 347 708 0418
This report studies the Myasthenia Gravis Therapeutics market, covering market size for segment by type (Surgery, Medication, etc.), by application (Hospitals, Academic Research Institutes, etc.), by sales channel (Direct Channel, Distribution Channel), by player (AbbVie, Alexion Pharmaceuticals, Avadel Pharmaceuticals, Bausch Health, Baxter International, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Myasthenia Gravis Therapeutics from 2016-2021, and provides extensive market forecasts from 2022-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Myasthenia Gravis Therapeutics market.
Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.
This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Leading players of Myasthenia Gravis Therapeutics including:
AbbVie
Alexion Pharmaceuticals
Avadel Pharmaceuticals
Bausch Health
Baxter International
Biogen
Bristol-Myers Squibb
Catalyst Pharmaceuticals
Cipla
CSL
Curavac
Cytokinetics
Flamel Technologies
Fresenius Kabi
Galencia
GlaxoSmithKline
Grifols
Lupin Pharmaceuticals
Mitsubishi Tanabe Pharma
Novartis
Pfizer
Piramal Healthcare
Roche
RPG Life Sciences
Sun Pharmaceuticals
Takeda Pharmaceutical
Teva Pharmaceutical
Valeant Pharmaceuticals
Market split by Type, can be divided into:
Surgery
Medication
Plasmapheresis and Intravenous Immunoglobulin
Autologous Hematopoietic Stem Cell Transplantation
Other
Market split by Application, can be divided into:
Hospitals
Academic Research Institutes
Clinics
Other
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
Table of Contents
Chapter 1 Myasthenia Gravis Therapeutics Market Overview
1.1 Myasthenia Gravis Therapeutics Definition
1.2 Global Myasthenia Gravis Therapeutics Market Size Status and Outlook (2016-2030)
1.3 Global Myasthenia Gravis Therapeutics Market Size Comparison by Region (2016-2030)
1.4 Global Myasthenia Gravis Therapeutics Market Size Comparison by Type (2016-2030)
1.5 Global Myasthenia Gravis Therapeutics Market Size Comparison by Application (2016-2030)
1.6 Global Myasthenia Gravis Therapeutics Market Size Comparison by Sales Channel (2016-2030)
1.7 Myasthenia Gravis Therapeutics Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Post-Strategies of COVID-19
Chapter 2 Myasthenia Gravis Therapeutics Market Segment Analysis by Player
2.1 Global Myasthenia Gravis Therapeutics Sales and Market Share by Player (2019-2021)
2.2 Global Myasthenia Gravis Therapeutics Revenue and Market Share by Player (2019-2021)
2.3 Global Myasthenia Gravis Therapeutics Average Price by Player (2019-2021)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Myasthenia Gravis Therapeutics Market Segment Analysis by Type
3.1 Global Myasthenia Gravis Therapeutics Market by Type
3.1.1 Surgery
3.1.2 Medication
3.1.3 Plasmapheresis and Intravenous Immunoglobulin
3.1.4 Autologous Hematopoietic Stem Cell Transplantation
3.1.5 Other
3.2 Global Myasthenia Gravis Therapeutics Sales and Market Share by Type (2016-2021)
3.3 Global Myasthenia Gravis Therapeutics Revenue and Market Share by Type (2016-2021)
3.4 Global Myasthenia Gravis Therapeutics Average Price by Type (2016-2021)
3.5 Leading Players of Myasthenia Gravis Therapeutics by Type in 2021
3.6 Conclusion of Segment by Type
Chapter 4 Myasthenia Gravis Therapeutics Market Segment Analysis by Application
4.1 Global Myasthenia Gravis Therapeutics Market by Application
4.1.1 Hospitals
4.1.2 Academic Research Institutes
4.1.3 Clinics
4.1.4 Other
4.2 Global Myasthenia Gravis Therapeutics Revenue and Market Share by Application (2016-2021)
4.3 Leading Consumers of Myasthenia Gravis Therapeutics by Application in 2021
4.4 Conclusion of Segment by Application
Chapter 5 Myasthenia Gravis Therapeutics Market Segment Analysis by Sales Channel
5.1 Global Myasthenia Gravis Therapeutics Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Myasthenia Gravis Therapeutics Revenue and Market Share by Sales Channel (2016-2021)
5.3 Leading Distributors/Dealers of Myasthenia Gravis Therapeutics by Sales Channel in 2021
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Myasthenia Gravis Therapeutics Market Segment Analysis by Region
6.1 Global Myasthenia Gravis Therapeutics Market Size and CAGR by Region (2016-2030)
6.2 Global Myasthenia Gravis Therapeutics Sales and Market Share by Region (2016-2021)
6.3 Global Myasthenia Gravis Therapeutics Revenue and Market Share by Region (2016-2021)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Myasthenia Gravis Therapeutics Market Share by Type
6.4.3 North America Myasthenia Gravis Therapeutics Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Myasthenia Gravis Therapeutics Market Share by Type
6.5.3 Europe Myasthenia Gravis Therapeutics Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Myasthenia Gravis Therapeutics Market Share by Type
6.6.3 Asia-Pacific Myasthenia Gravis Therapeutics Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Myasthenia Gravis Therapeutics Market Share by Type
6.7.3 South America Myasthenia Gravis Therapeutics Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Myasthenia Gravis Therapeutics Market Share by Type
6.8.3 Middle East & Africa Myasthenia Gravis Therapeutics Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Myasthenia Gravis Therapeutics Players
7.1 AbbVie
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Alexion Pharmaceuticals
7.3 Avadel Pharmaceuticals
7.4 Bausch Health
7.5 Baxter International
7.6 Biogen
7.7 Bristol-Myers Squibb
7.8 Catalyst Pharmaceuticals
7.9 Cipla
7.10 CSL
7.11 Curavac
7.12 Cytokinetics
7.13 Flamel Technologies
7.14 Fresenius Kabi
7.15 Galencia
7.16 GlaxoSmithKline
7.17 Grifols
7.18 Lupin Pharmaceuticals
7.19 Mitsubishi Tanabe Pharma
7.20 Novartis
7.21 Pfizer
7.22 Piramal Healthcare
7.23 Roche
7.24 RPG Life Sciences
7.25 Sun Pharmaceuticals
7.26 Takeda Pharmaceutical
7.27 Teva Pharmaceutical
7.28 Valeant Pharmaceuticals
Chapter 8 Upstream and Downstream Analysis of Myasthenia Gravis Therapeutics
8.1 Industrial Chain of Myasthenia Gravis Therapeutics
8.2 Upstream of Myasthenia Gravis Therapeutics
8.3 Downstream of Myasthenia Gravis Therapeutics
Chapter 9 Development Trend of Myasthenia Gravis Therapeutics (2022-2030)
9.1 Global Myasthenia Gravis Therapeutics Market Size (Sales and Revenue) Forecast (2022-2030)
9.2 Global Myasthenia Gravis Therapeutics Market Size and CAGR Forecast by Region (2022-2030)
9.3 Global Myasthenia Gravis Therapeutics Market Size and CAGR Forecast by Type (2022-2030)
9.4 Global Myasthenia Gravis Therapeutics Market Size and CAGR Forecast by Application (2022-2030)
9.5 Global Myasthenia Gravis Therapeutics Market Size and CAGR Forecast by Sales Channel (2022-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure Myasthenia Gravis Therapeutics Example
Figure Global Myasthenia Gravis Therapeutics Revenue (Million $) Status and Outlook (2016-2030)
Figure Global Myasthenia Gravis Therapeutics Revenue (Million $) Comparison by Region (2016-2030)
Figure Global Myasthenia Gravis Therapeutics Revenue (Million $) Comparison by Type (2016-2030)
Figure Global Myasthenia Gravis Therapeutics Revenue (Million $) Comparison by Application (2016-2030)
Figure Global Myasthenia Gravis Therapeutics Revenue (Million $) Comparison by Sales Channel (2016-2030)
Table Global Myasthenia Gravis Therapeutics Sales by Player (2019-2021)
Table Global Myasthenia Gravis Therapeutics Sales Market Share by Player (2019-2021)
Figure Global Myasthenia Gravis Therapeutics Sales Market Share by Player in 2021
Table Global Myasthenia Gravis Therapeutics Revenue (Million $) by Player (2019-2021)
Table Global Myasthenia Gravis Therapeutics Revenue Market Share by Player (2019-2021)
Figure Global Myasthenia Gravis Therapeutics Revenue Market Share by Player in 2021
Table Global Myasthenia Gravis Therapeutics Average Price by Player (2019-2021)
Figure Global Myasthenia Gravis Therapeutics Average Price by Player in 2021
Figure Global Myasthenia Gravis Therapeutics Players Competition Situation Top 5 Players Revenue Market Share in 2019
Figure Global Myasthenia Gravis Therapeutics Players Competition Trends Top 5 Players Revenue Market Share in 2021
Figure Example of Surgery
Figure Global Surgery Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Medication
Figure Global Medication Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Plasmapheresis and Intravenous Immunoglobulin
Figure Global Plasmapheresis and Intravenous Immunoglobulin Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Autologous Hematopoietic Stem Cell Transplantation
Figure Global Autologous Hematopoietic Stem Cell Transplantation Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Other
Figure Global Other Revenue (Million $) and Growth Rate (2016-2021)
Table Global Myasthenia Gravis Therapeutics Sales by Type (2016-2021)
Table Global Myasthenia Gravis Therapeutics Sales Market Share by Type (2016-2021)
Figure Global Myasthenia Gravis Therapeutics Sales Market Share by Type in 2021
Table Global Myasthenia Gravis Therapeutics Revenue (Million $) by Type (2016-2021)
Table Global Myasthenia Gravis Therapeutics Revenue Market Share by Type (2016-2021)
Figure Global Myasthenia Gravis Therapeutics Revenue Market Share by Type in 2021
Table Global Myasthenia Gravis Therapeutics Average Price by Type (2016-2021)
Figure Global Myasthenia Gravis Therapeutics Average Price by Type in 2021
Table Leading Players of Myasthenia Gravis Therapeutics by Type in 2021
Figure Example of Hospitals
Figure Global Myasthenia Gravis Therapeutics for Hospitals Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Academic Research Institutes
Figure Global Myasthenia Gravis Therapeutics for Academic Research Institutes Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Clinics
Figure Global Myasthenia Gravis Therapeutics for Clinics Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Other
Figure Global Myasthenia Gravis Therapeutics for Other Revenue (Million $) and Growth Rate (2016-2021)
Table Global Myasthenia Gravis Therapeutics Sales by Application (2016-2021)
Table Global Myasthenia Gravis Therapeutics Sales Market Share by Application (2016-2021)
Figure Global Myasthenia Gravis Therapeutics Sales Market Share by Application in 2021
Table Leading Consumers of Myasthenia Gravis Therapeutics by Application in 2021
Figure Example of Direct Channel
Figure Global Myasthenia Gravis Therapeutics for Direct Channel Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Distribution Channel
Figure Global Myasthenia Gravis Therapeutics for Distribution Channel Revenue (Million $) and Growth Rate (2016-2021)
Table Global Myasthenia Gravis Therapeutics Revenue by Sales Channel (2016-2021)
Table Global Myasthenia Gravis Therapeutics Revenue Market Share by Sales Channel (2016-2021)
Figure Global Myasthenia Gravis Therapeutics Revenue Market Share by Sales Channel in 2021
Table Leading Distributors/Dealers of Myasthenia Gravis Therapeutics by Sales Channel in 2021
Table Global Myasthenia Gravis Therapeutics Market Size and CAGR by Region (2016-2030)
Table Global Myasthenia Gravis Therapeutics Sales by Region (2016-2021)
Table Global Myasthenia Gravis Therapeutics Sales Market Share by Region (2016-2021)
Figure Global Myasthenia Gravis Therapeutics Sales Market Share by Region in 2021
Table Global Myasthenia Gravis Therapeutics Revenue (Million $) by Region (2016-2021)
Table Global Myasthenia Gravis Therapeutics Revenue Market Share by Region (2016-2021)
Figure Global Myasthenia Gravis Therapeutics Revenue Market Share by Region in 2021
Table North America Myasthenia Gravis Therapeutics Sales by Country (2016-2021)
Figure North America Myasthenia Gravis Therapeutics Sales Market Share by Country (2016-2021)
Table North America Myasthenia Gravis Therapeutics Revenue by Country (2016-2021)
Figure North America Myasthenia Gravis Therapeutics Revenue Market Share by Country (2016-2021)
Figure North America Myasthenia Gravis Therapeutics Market Share by Type in 2021
Figure North America Myasthenia Gravis Therapeutics Market Share by Application in 2021
Figure United States Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure United States Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Canada Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure Canada Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Mexico Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure Mexico Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Table Europe Myasthenia Gravis Therapeutics Sales by Country (2016-2021)
Figure Europe Myasthenia Gravis Therapeutics Sales Market Share by Country (2016-2021)
Table Europe Myasthenia Gravis Therapeutics Revenue by Country (2016-2021)
Figure Europe Myasthenia Gravis Therapeutics Revenue Market Share by Country (2016-2021)
Figure Europe Myasthenia Gravis Therapeutics Market Share by Type in 2021
Figure Europe Myasthenia Gravis Therapeutics Market Share by Application in 2021
Figure Germany Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure Germany Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure UK Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure UK Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure France Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure France Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Italy Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure Italy Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Russia Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure Russia Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Spain Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure Spain Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Table Asia-Pacific Myasthenia Gravis Therapeutics Sales by Country (2016-2021)
Figure Asia-Pacific Myasthenia Gravis Therapeutics Sales Market Share by Country (2016-2021)
Table Asia-Pacific Myasthenia Gravis Therapeutics Revenue by Country (2016-2021)
Figure Asia-Pacific Myasthenia Gravis Therapeutics Revenue Market Share by Country (2016-2021)
Figure Asia-Pacific Myasthenia Gravis Therapeutics Market Share by Type in 2021
Figure Asia-Pacific Myasthenia Gravis Therapeutics Market Share by Application in 2021
Figure China Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure China Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Japan Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure Japan Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Korea Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure Korea Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure India Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure India Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Southeast Asia Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure Southeast Asia Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Australia Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure Australia Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Table South America Myasthenia Gravis Therapeutics Sales by Country (2016-2021)
Figure South America Myasthenia Gravis Therapeutics Sales Market Share by Country (2016-2021)
Table South America Myasthenia Gravis Therapeutics Revenue by Country (2016-2021)
Figure South America Myasthenia Gravis Therapeutics Revenue Market Share by Country (2016-2021)
Figure South America Myasthenia Gravis Therapeutics Market Share by Type in 2021
Figure South America Myasthenia Gravis Therapeutics Market Share by Application in 2021
Figure Brazil Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure Brazil Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Argentina Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure Argentina Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Colombia Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure Colombia Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Table Middle East & Africa Myasthenia Gravis Therapeutics Sales by Country (2016-2021)
Figure Middle East & Africa Myasthenia Gravis Therapeutics Sales Market Share by Country (2016-2021)
Table Middle East & Africa Myasthenia Gravis Therapeutics Revenue by Country (2016-2021)
Figure Middle East & Africa Myasthenia Gravis Therapeutics Revenue Market Share by Country (2016-2021)
Figure Middle East & Africa Myasthenia Gravis Therapeutics Market Share by Type in 2021
Figure Middle East & Africa Myasthenia Gravis Therapeutics Market Share by Application in 2021
Figure UAE Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure UAE Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Saudi Arabia Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure Saudi Arabia Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure South Africa Myasthenia Gravis Therapeutics Sales and Growth Rate (2016-2021)
Figure South Africa Myasthenia Gravis Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Table Company Snapshot of AbbVie
Table Myasthenia Gravis Therapeutics Introduction of AbbVie
Table Myasthenia Gravis Therapeutics Sales, Price, Revenue, Gross Margin and Market Share of AbbVie (2019-2021)
Table Industrial Chain of Myasthenia Gravis Therapeutics
Table Manufacturing Cost Structure of Myasthenia Gravis Therapeutics
Table General Manufacturing Process of Myasthenia Gravis Therapeutics
Table Leading Distributors/Dealers of Myasthenia Gravis Therapeutics
Table Leading Consumers of Myasthenia Gravis Therapeutics
Figure Global Myasthenia Gravis Therapeutics Sales and Growth Rate Forecast (2022-2030)
Figure Global Myasthenia Gravis Therapeutics Revenue and Growth Rate Forecast (2022-2030)
Table Global Myasthenia Gravis Therapeutics Market Size and CAGR Forecast by Region (2022-2030)
Table Global Myasthenia Gravis Therapeutics Market Size and CAGR Forecast by Type (2022-2030)
Table Global Myasthenia Gravis Therapeutics Market Size and CAGR Forecast by Application (2022-2030)
Table Global Myasthenia Gravis Therapeutics Market Size and CAGR Forecast by Sales Channel (2022-2030)
Buy
